Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 25, No 2 (January 10), 2007: pp. 180-186
© 2007 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2006.09.6081

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meropol, N. J.
Right arrow Articles by Schulman, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meropol, N. J.
Right arrow Articles by Schulman, K. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

REVIEW ARTICLE

Cost of Cancer Care: Issues and Implications

Neal J. Meropol, Kevin A. Schulman

From the Divisions of Medical Science and Population Science, Fox Chase Cancer Center, Philadelphia, PA; and the Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC

Address reprint requests to Neal J. Meropol, MD, Fox Chase Cancer Center, 333 Cottman Ave, Room C307, Philadelphia, PA 19111; e-mail: neal.meropol{at}fccc.edu

Medical technology is increasingly costly in most fields of clinical medicine. Oncology has not been spared from issues related to cost, in part resulting from the tremendous scientific progress that has lead to new tools for diagnosis, treatment, and follow-up of our patients. The increasing cost of health care in general (and cancer care in particular) raises complex questions related to its effects on our economy and the citizens of our society. This article reviews the macroeconomic principles and individual behaviors that govern medical spending, and examines how cost disproportionately affects various populations. Our overall goal is to frame debate about health policy concerns that influence the clinical practice of oncology.

Presented in part in written format in the 2005 Ameican Society of Clinical Oncology Educational Book.

Authors' discolsures of potential conflicts of interest and author contributions are found at the end of this article.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
The OncologistHome page
T. J. Smith and B. E. Hillner
Concrete Options and Ideas for Increasing Value in Oncology Care: The View from One Trench
Oncologist, March 1, 2010; 15(suppl_1): 65 - 72.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
A. Schickedanz
Of Value: A Discussion of Cost, Communication, and Evidence to Improve Cancer Care
Oncologist, March 1, 2010; 15(suppl_1): 73 - 79.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
D. Greenberg, C. Earle, C.-H. Fang, A. Eldar-Lissai, and P. J. Neumann
When is Cancer Care Cost-Effective? A Systematic Overview of Cost-Utility Analyses in Oncology
J Natl Cancer Inst, January 20, 2010; 102(2): 82 - 88.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. W. Saif, A. Choma, S. J. Salamone, and E. Chu
Pharmacokinetically Guided Dose Adjustment of 5-Fluorouracil: A Rational Approach to Improving Therapeutic Outcomes
J Natl Cancer Inst, November 18, 2009; 101(22): 1543 - 1552.
[Abstract] [Full Text] [PDF]


Home page
J Oncol PractHome page
J. M. Luna, P. W. Thurman, M. Wolfe, D. Yagoda, E. Reed, and W. D. Figg Sr
Private Practice Administrative Costs Influenced by Insurance Payer Mix
J. Oncol. Pract, November 1, 2009; 5(6): 291 - 297.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
K. R. Yabroff and D. Schrag
Challenges and Opportunities for Use of Cost-Effectiveness Analysis
J Natl Cancer Inst, September 2, 2009; 101(17): 1161 - 1163.
[Full Text] [PDF]


Home page
JCOHome page
N. J. Meropol, D. Schrag, T. J. Smith, T. M. Mulvey, R. M. Langdon Jr, D. Blum, P. A. Ubel, and L. E. Schnipper
American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care
J. Clin. Oncol., August 10, 2009; 27(23): 3868 - 3874.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
W. F. Anderson
Cancer Surveillance Research
Cancer Epidemiol. Biomarkers Prev., June 1, 2009; 18(6): 1669 - 1671.
[Full Text] [PDF]


Home page
JCOHome page
S. D. Reed, Y. Li, K. J. Anstrom, and K. A. Schulman
Cost Effectiveness of Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment
J. Clin. Oncol., May 1, 2009; 27(13): 2185 - 2191.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. F. Wilson
Cancer Care: A Microcosm of the Problems Facing All of Health Care
Ann Intern Med, April 21, 2009; 150(8): 573 - 576.
[Full Text] [PDF]


Home page
NEJMHome page
P. B. Bach
Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs
N. Engl. J. Med., February 5, 2009; 360(6): 626 - 633.
[Full Text] [PDF]


Home page
JCOHome page
J. Peppercorn, H. Burstein, F. G. Miller, E. Winer, and S. Joffe
Self-Reported Practices and Attitudes of US Oncologists Regarding Off-Protocol Therapy
J. Clin. Oncol., December 20, 2008; 26(36): 5994 - 6000.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. McFarlane, J. Riggins, and T. J. Smith
SPIKE$: A Six-Step Protocol for Delivering Bad News About the Cost of Medical Care
J. Clin. Oncol., September 1, 2008; 26(25): 4200 - 4204.
[Full Text] [PDF]


Home page
CA Cancer J ClinHome page
Y.-C. T. Shih and M. T. Halpern
Economic Evaluations of Medical Care Interventions for Cancer Patients: How, Why, and What Does it Mean?
CA Cancer J Clin, July 1, 2008; 58(4): 231 - 244.
[Abstract] [Full Text] [PDF]


Home page
Med Decis MakingHome page
I. Hozo and B. Djulbegovic
When Is Diagnostic Testing Inappropriate or Irrational? Acceptable Regret Approach
Med Decis Making, July 1, 2008; 28(4): 540 - 553.
[Abstract] [PDF]


Home page
JAMAHome page
S. E. Harrington and T. J. Smith
The Role of Chemotherapy at the End of Life: "When Is Enough, Enough?"
JAMA, June 11, 2008; 299(22): 2667 - 2678.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. J. Mayer
Should Capecitabine Replace Infusional Fluorouracil and Leucovorin When Combined With Oxaliplatin in Metastatic Colorectal Cancer?
J. Clin. Oncol., September 20, 2007; 25(27): 4165 - 4167.
[Full Text] [PDF]


Home page
JCOHome page
N. J. Meropol and K. A. Schulman
In Reply
J. Clin. Oncol., August 1, 2007; 25(22): 3383 - 3383.
[Full Text] [PDF]


Home page
JCOHome page
N. J. Meropol and K. A. Schulman
Perspectives on the Cost of Cancer Care
J. Clin. Oncol., January 10, 2007; 25(2): 169 - 170.
[Full Text] [PDF]


Home page
JCOHome page
P. A. Grusenmeyer and Y.-N. Wong
Interpreting the Economic Literature in Oncology
J. Clin. Oncol., January 10, 2007; 25(2): 196 - 202.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2007 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online